Odyssey Health (ODYY) Common Equity (2014 - 2026)

Odyssey Health has disclosed Common Equity across 13 years of filings, most recently posting -$9.7 million for Q2 2026.

• Quarterly Common Equity fell 245.46% year-over-year to -$9.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$9.7 million (down 245.46% YoY) and the FY2025 annual result came in at -$7.0 million, down 30.39% from the prior year.
• Common Equity advanced to -$9.7 million in Q2 2026, from -$10.6 million in the prior quarter.
• Across five years, Common Equity topped out at $8.7 million in Q1 2024 and bottomed at -$10.6 million in Q1 2026.
• The 5-year median for Common Equity is -$5.6 million (2022), against an average of -$4.0 million.
• Year-over-year, Common Equity plunged 330.85% in 2022 and surged 261.56% in 2024.
• Odyssey Health's Common Equity stood at -$5.4 million in 2022, then decreased by 15.5% to -$6.2 million in 2023, then decreased by 0.97% to -$6.3 million in 2024, then fell by 13.96% to -$7.2 million in 2025, then tumbled by 36.26% to -$9.7 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered -$9.7 million, -$10.6 million, and -$7.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.